Patents by Inventor Emeka Enwere

Emeka Enwere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8435949
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: May 7, 2013
    Assignee: Stem Cell Therapeutics Corp.
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg
  • Publication number: 20120244111
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Application
    Filed: June 11, 2012
    Publication date: September 27, 2012
    Applicant: Stem Cell Therapeutics Corp.
    Inventors: Samuel WEISS, Emeka ENWERE, Linda ANDERSEN, Christopher GREGG
  • Patent number: 8217002
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: July 10, 2012
    Assignee: Stem Cell Therapeutics Corp.
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg
  • Publication number: 20110178009
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Application
    Filed: October 29, 2010
    Publication date: July 21, 2011
    Applicant: STEM CELL THERAPEUTICS CORP.
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg
  • Patent number: 7846898
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: December 7, 2010
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg
  • Publication number: 20060105958
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Application
    Filed: September 12, 2005
    Publication date: May 18, 2006
    Applicant: STEM CELL THERAPEUTICS CORP.
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg
  • Publication number: 20050245436
    Abstract: The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
    Type: Application
    Filed: February 14, 2005
    Publication date: November 3, 2005
    Applicant: Stem Cell Therapeutics Corp.
    Inventors: Samuel Weiss, Emeka Enwere, Linda Andersen, Christopher Gregg